Anavex Life Sciences Corp. SEC filings AVXL
Anavex Life Sciences Corp. has 634 filings in SEC EDGAR's recent list, going back to Jan 13, 2005. Its latest annual report, Form 10-K, was filed on Nov 25, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 28, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DFAN14A | Filing | Sep 21, 2026 | — |
| DFAN14A | Filing | Sep 18, 2026 | — |
| DFAN14A | Filing | Sep 17, 2026 | — |
| DFAN14A | Filing | Sep 15, 2026 | — |
| DFAN14A | Filing | Sep 10, 2026 | — |
| DFAN14A | Filing | Sep 10, 2026 | — |
| DFAN14A | Filing | Sep 9, 2026 | — |
| DFAN14A | Filing | Sep 4, 2026 | — |
| DFAN14A | Filing | Sep 3, 2026 | — |
| DFAN14A | Filing | Sep 2, 2026 | — |
| DEFC14A | Filing | Aug 27, 2026 | — |
| PRRN14A | Filing | Aug 27, 2026 | — |
| DFAN14A | Filing | Aug 20, 2026 | — |
| PRRN14A | Filing | Aug 18, 2026 | — |
| DEFC14A | Form defc14a | Aug 11, 2026 | — |
| NT 10-Q | Form nt 10-q | Aug 10, 2026 | Jun 30, 2026 |
| PREC14A | Form prec14a | Jul 31, 2026 | — |
| PREC14A | Filing | Jul 24, 2026 | — |
| NT 10-Q | Form nt 10-q | May 11, 2026 | Mar 31, 2026 |
| EFFECT | Filing | Jul 23, 2025 | — |
| CORRESP | Letter to the SEC | Jul 21, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| EFFECT | Filing | Sep 20, 2019 | — |
| AW | Filing | Sep 16, 2019 | — |
| EFFECT | Filing | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 12, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2019 | — |
| EFFECT | Filing | Jun 12, 2017 | — |
| CORRESP | Letter to the SEC | Jun 9, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2017 | — |
| EFFECT | Filing | Sep 6, 2016 | — |
| CORRESP | Letter to the SEC | Sep 1, 2016 | — |
| CORRESP | Letter to the SEC | Aug 30, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2015 | — |
| CERTNAS | Auto-generated paper document | Oct 23, 2015 | — |
| 8-A12B | Form 8-a12b | Oct 23, 2015 | — |
| EFFECT | Filing | Jul 8, 2015 | — |
| EFFECT | Filing | Mar 24, 2015 | — |
| EFFECT | Filing | Aug 22, 2014 | — |
| EFFECT | Filing | Jul 23, 2014 | — |
| CORRESP | Letter to the SEC | Jul 22, 2014 | — |
| CORRESP | Letter to the SEC | Jun 13, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2014 | — |
| CORRESP | Letter to the SEC | May 22, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2014 | — |
| D | Filing | Apr 2, 2014 | — |
| EFFECT | Filing | Oct 23, 2013 | — |
| EFFECT | Filing | Oct 1, 2013 | — |
| NT 10-Q | Form nt 10-q | May 15, 2013 | Mar 31, 2013 |
| NT 10-Q | Form nt 10-q | Aug 15, 2012 | Jun 30, 2012 |
| D | Filing | Feb 16, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2011 | — |
| D | Filing | Nov 26, 2010 | — |
| CT ORDER | Filing | Sep 21, 2010 | — |
| NT 10-Q | Filing | Aug 17, 2010 | Jun 30, 2010 |
| D | Filing | Jul 6, 2010 | — |
| NT 10-Q | Notification of late filing | May 17, 2010 | Mar 31, 2010 |
| UPLOAD | Letter from the SEC | Apr 23, 2010 | — |
| CORRESP | Letter to the SEC | Mar 26, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2010 | — |
| NT 10-Q | Form nt | Feb 17, 2010 | Dec 31, 2009 |
| NT 10-Q | Filing | Aug 17, 2009 | Jun 30, 2009 |
| NT 10-Q | Filing | May 18, 2009 | Mar 31, 2009 |
| NT 10-Q | Filing | Feb 17, 2009 | Dec 31, 2008 |
| NT 10-K | Filing | Dec 30, 2008 | Sep 30, 2008 |
| 10QSB | Quarterly report for the period ended june 30, 2008 | Aug 18, 2008 | Jun 30, 2008 |
| NT 10-Q | Form nt | Aug 14, 2008 | Jun 30, 2008 |
| 10QSB | Quarterly report for the period ended march 31, 2008 | May 15, 2008 | Mar 31, 2008 |
| UPLOAD | Letter from the SEC | Mar 11, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2008 | — |
| 10QSB/A | Amendment no. 1 to quarterly report for the period ended december 31, 2007 | Feb 19, 2008 | Dec 31, 2007 |
| CORRESP | Letter to the SEC | Feb 15, 2008 | — |
| 10QSB | Filing | Feb 14, 2008 | Dec 31, 2007 |
| UPLOAD | Letter from the SEC | Feb 11, 2008 | — |
| 10KSB | Annual report for the fiscal year ended september 30, 2007 | Jan 15, 2008 | Sep 30, 2007 |
| NT 10-K | Form nt | Dec 31, 2007 | Sep 30, 2007 |
| 10QSB | Filing | Aug 14, 2007 | Jun 30, 2007 |
| 10QSB | Filing | May 15, 2007 | Mar 31, 2007 |
| 10QSB | Form 10-qsb | Feb 14, 2007 | Dec 31, 2006 |
| 10KSB | Form 10-ksb (september 30, 2006) | Dec 21, 2006 | Sep 30, 2006 |
| 10QSB/A | Filing | Aug 10, 2006 | Jun 30, 2006 |
| 10QSB/A | Filing | Aug 9, 2006 | Jun 30, 2006 |
| 10QSB | Filing | Aug 9, 2006 | Jun 30, 2006 |
| 10QSB | Filing | May 16, 2006 | Mar 31, 2006 |
| SC 14F1 | Filing | May 3, 2006 | — |
| 10QSB | Form 10qsb | Feb 10, 2006 | Dec 31, 2005 |
| 10KSB | Form 10ksb | Dec 29, 2005 | Sep 30, 2005 |
| 8-A12G | Form 8-a | Dec 6, 2005 | — |
| AW WD | Letter withdrawing filing | Dec 6, 2005 | — |
| CORRESP | Letter to the SEC | Nov 9, 2005 | — |
| SB-2/A | Version 5 of sb-2 | Oct 31, 2005 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2005 | — |
| SB-2/A | Filing | Sep 15, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2005 | — |
| SB-2/A | Filing | Jul 29, 2005 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2005 | — |
| SB-2/A | Filing | Jun 9, 2005 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2005 | — |
| SB-2/A | Filing | Mar 17, 2005 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2005 | — |
| SB-2 | Filing | Jan 13, 2005 | — |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AVXL (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer, Smaller reporting company
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc. (until Jan 25, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.